Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02193646
Other study ID # ESA-2014
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 2010
Est. completion date January 2026

Study information

Verified date November 2023
Source Rush University Medical Center
Contact Amanda Lin
Phone 3125633907
Email amanda_f_lin@rush.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators are retrospectively comparing detection rates of adenomatous polyps, advanced adenomas, and size assessment of the polyps among Rush University Medical Center endoscopists. The investigators plan to review whether the size assessment of adenomatous polyps affected the surveillance protocols and if the location of polyps detected affected the detection rates.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date January 2026
Est. primary completion date January 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Presence of adenomatous polyps detected at endoscopy and diagnosed pathologically by tissue biopsy - Have a colonoscopy at RUMC for screening purposes Exclusion Criteria: - Failure to meet inclusion criteria - Previous diagnosis of IBD or colorectal cancer

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Amanda Lin Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Rush University Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adenomatous Polyp Detection Rate Assessing for advanced adenomas (including location). one year
Primary Endoscopic Size Assessment Versus Pathological Size Assessment Size of polyps at time of endoscopic procedure will be compared to the size of the same polyp by pathological assessment. one year
Secondary Retroflexion as an indication of adenoma detection rate in colorectal cancer screening Retroflexion is a common but not mandatory practice in colonoscopy which as not been systematically studied in terms of polyp detection. Charts will be reviewed to determine whether retroflexion was performed. one year